Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

27.91
+0.36001.31%
Post-market: 27.910.00000.00%16:10 EDT
Volume:1K
Turnover:30.31K
Market Cap:5.58M
PE:- -
High:27.94
Open:27.94
Low:27.88
Close:27.55
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.20
T/O Rate:0.54%
Dividend:0.41
Dividend Rate:1.48%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk (NVO) Stock May Trade Below Fair Value Despite Obesity Market Lawsuit

Simply Wall St.
·
4 hours ago

How GLP-1 Sales Could Play Out for Hims & Hers

Dow Jones
·
5 hours ago

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
7 hours ago

Novo Nordisk A/S Stock (NVO) Closed Up by 3.71% on Aug 25: A Full Analysis

TradingKey
·
7 hours ago

Eli Lilly Stock (LLY) Rattled as Companies Decline to Cover Weight-Loss Drug Costs

TIPRANKS
·
9 hours ago

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
10 hours ago

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
11 hours ago

Novo Nordisk price target raised to DKK 275 from DKK 250 at JPMorgan

TIPRANKS
·
12 hours ago

Novo Nordisk call volume above normal and directionally bullish

TIPRANKS
·
Yesterday

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Yesterday

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Yesterday

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Yesterday

Novo Nordisk Sales Growth Could Remain Flat This Year

Dow Jones
·
Yesterday

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Yesterday

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position

TIPRANKS
·
Yesterday

Der Aktionaer editor speculates on timing of Viking Therapeutics data

TIPRANKS
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating

MT Newswires Live
·
Yesterday